Literature DB >> 12595464

Amino acid sequence requirements in the hinge of human immunoglobulin A1 (IgA1) for cleavage by streptococcal IgA1 proteases.

Margaret R Batten1, Bernard W Senior, Mogens Kilian, Jenny M Woof.   

Abstract

The amino acid sequence requirements in the hinge of human immunoglobulin A1 (IgA1) for cleavage by IgA1 proteases of different species of Streptococcus were investigated. Recombinant IgA1 antibodies were generated with point mutations at proline 227 and threonine 228, the residues lying on either side of the peptide bond at which all streptococcal IgA1 proteases cleave wild-type human IgA1. The amino acid substitutions produced no major effect upon the structure of the mutant IgA1 antibodies or their functional ability to bind to Fcalpha receptors. However, the substitutions had a substantial effect upon sensitivity to cleavage with some streptococcal IgA1 proteases, with, in some cases, a single point mutation rendering the antibody resistant to a particular IgA1 protease. This effect was least marked with the IgA1 protease from Streptococcus pneumoniae, which showed no absolute requirement for either proline or threonine at residues 227 to 228. By contrast, the IgA1 proteases of Streptococcus oralis, Streptococcus sanguis, and Streptococcus mitis had an absolute requirement for proline at 227 but not for threonine at 228, which could be replaced by valine. There was evidence in S. mitis that proteases from different strains may have different amino acid requirements for cleavage. Remarkably, some streptococcal proteases appeared able to cleave the hinge at a distant alternative site if substitution prevented efficient cleavage of the original site. Hence, this study has identified key residues required for the recognition of the IgA1 hinge as a substrate by streptococcal IgA1 proteases, and it marks a preliminary step towards development of specific enzyme inhibitors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12595464      PMCID: PMC148859          DOI: 10.1128/IAI.71.3.1462-1469.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  Evidence of recombination and an antigenically diverse immunoglobulin A1 protease among strains of Streptococcus pneumoniae.

Authors:  H Lomholt
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

2.  Inhibition of IgA1 proteinases from Neisseria gonorrhoeae and Hemophilus influenzae by peptide prolyl boronic acids.

Authors:  W W Bachovchin; A G Plaut; G R Flentke; M Lynch; C A Kettner
Journal:  J Biol Chem       Date:  1990-03-05       Impact factor: 5.157

3.  Increased proportions of bacteria capable of cleaving IgA1 in the pharynx of infants with atopic disease.

Authors:  M Kilian; S Husby; A Høst; S Halken
Journal:  Pediatr Res       Date:  1995-08       Impact factor: 3.756

4.  Analysis of the specificity of bacterial immunoglobulin A (IgA) proteases by a comparative study of ape serum IgAs as substrates.

Authors:  J Qiu; G P Brackee; A G Plaut
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

5.  Purification and characterization of chimeric human IgA1 and IgA2 expressed in COS and Chinese hamster ovary cells.

Authors:  H C Morton; J D Atkin; R J Owens; J M Woof
Journal:  J Immunol       Date:  1993-11-01       Impact factor: 5.422

6.  Analysis of the immunoglobulin A protease gene of Streptococcus sanguis.

Authors:  J V Gilbert; A G Plaut; A Wright
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

7.  Mutagenesis of the human IgA1 heavy chain tailpiece that prevents dimer assembly.

Authors:  J D Atkin; R J Pleass; R J Owens; J M Woof
Journal:  J Immunol       Date:  1996-07-01       Impact factor: 5.422

8.  Antibodies against IgA1 protease are stimulated both by clinical disease and asymptomatic carriage of serogroup A Neisseria meningitidis.

Authors:  G F Brooks; C J Lammel; M S Blake; B Kusecek; M Achtman
Journal:  J Infect Dis       Date:  1992-12       Impact factor: 5.226

9.  Post-infectious human serum antibodies inhibit IgA1 proteinases by interaction with the cleavage site specificity determinant.

Authors:  A G Devenyi; A G Plaut; F J Grundy; A Wright
Journal:  Mol Immunol       Date:  1993-10       Impact factor: 4.407

10.  Localization of the binding site for the monocyte immunoglobulin (Ig) A-Fc receptor (CD89) to the domain boundary between Calpha2 and Calpha3 in human IgA1.

Authors:  L Carayannopoulos; J M Hexham; J D Capra
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

View more
  13 in total

1.  Polymorphism of the IGHA gene in sheep.

Authors:  Huitong Zhou; Jon G H Hickford; Qian Fang
Journal:  Immunogenetics       Date:  2005-07-16       Impact factor: 2.846

2.  Development of a high-throughput screen and its use in the discovery of Streptococcus pneumoniae immunoglobulin A1 protease inhibitors.

Authors:  Amanda L Garner; Jessica L Fullagar; Joshua A Day; Seth M Cohen; Kim D Janda
Journal:  J Am Chem Soc       Date:  2013-06-28       Impact factor: 15.419

3.  Effect of mutations in the human immunoglobulin A1 (IgA1) hinge on its susceptibility to cleavage by diverse bacterial IgA1 proteases.

Authors:  Bernard W Senior; Jenny M Woof
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

4.  Rabbit IgA Hinges That Resist IgA1 Protease Action Provide Options for Improved IgA-Based Therapeutic Agents.

Authors:  Patrícia de Sousa-Pereira; Dennis K Lanning; Pedro J Esteves; Christian Spoerry; Jenny M Woof; Ana Pinheiro
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

5.  Immunoglobulin A Glycosylation and Its Role in Disease.

Authors:  Alyssa L Hansen; Colin Reily; Jan Novak; Matthew B Renfrow
Journal:  Exp Suppl       Date:  2021

6.  Identification of four allelic variants of the dog IGHA gene.

Authors:  Iain R Peters; Chris R Helps; Emma L Calvert; Edward J Hall; Michael J Day
Journal:  Immunogenetics       Date:  2004-07-07       Impact factor: 2.846

7.  The expression of soluble and active recombinant Haemophilus influenzae IgA1 protease in E. coli.

Authors:  Shinong Long; Elaine Phan; Michel C Vellard
Journal:  J Biomed Biotechnol       Date:  2010-11-30

8.  Active-site gating regulates substrate selectivity in a chymotrypsin-like serine protease the structure of haemophilus influenzae immunoglobulin A1 protease.

Authors:  Troy A Johnson; Jiazhou Qiu; Andrew G Plaut; Todd Holyoak
Journal:  J Mol Biol       Date:  2009-04-23       Impact factor: 5.469

9.  Limited role of charge matching in the interaction of human immunoglobulin A with the immunoglobulin A Fc receptor (Fc alpha RI) CD89.

Authors:  Richard J Pleass; Prabhjyot K Dehal; Melanie J Lewis; Jenny M Woof
Journal:  Immunology       Date:  2003-07       Impact factor: 7.397

10.  Computational analyses of an evolutionary arms race between mammalian immunity mediated by immunoglobulin A and its subversion by bacterial pathogens.

Authors:  Ana Pinheiro; Jenny M Woof; Laurent Abi-Rached; Peter Parham; Pedro J Esteves
Journal:  PLoS One       Date:  2013-09-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.